Trinity Biotech Announces Quarter 1 Results
April 29, 2014 09:54 ET
|
Trinity Biotech plc
Revenues Up 23%, Operating Profit Up 16%
Increase in Dividend to 22 Cents
DUBLIN, April 29, 2014 (GLOBE NEWSWIRE) --Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of...
Trinity Biotech plc to Announce First Quarter Fiscal Year 2014 Financial Results
April 16, 2014 08:43 ET
|
Trinity Biotech plc
DUBLIN, April 16, 2014 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will...
Trinity Biotech Announces Results for Q4 and Fiscal Year 2013
March 04, 2014 09:31 ET
|
Trinity Biotech plc
DUBLIN, March 4, 2014 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today...
Trinity Biotech plc to Announce Fourth Quarter and Fiscal Year 2013 Financial Results
February 19, 2014 08:07 ET
|
Trinity Biotech plc
DUBLIN, Feb. 19, 2014 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will...
Trinity Biotech Announces European Approval of Guideline Compliant, Point-of-Care, High Sensitivity Troponin I Product
January 29, 2014 08:27 ET
|
Trinity Biotech plc
DUBLIN, Jan. 29, 2014 (GLOBE NEWSWIRE) -- Trinity Biotech plc. (Nasdaq:TRIB) today announced it has obtained the CE mark (i.e. European approval) for its Meritas, high sensitivity Troponin I (hsTnI)...
Trinity Biotech Announces Quarter 3 Financial Results, Acquisition of Blood Bank Screening Business and FDA Approval of HIV-2 Claim
October 17, 2013 09:27 ET
|
Trinity Biotech plc
DUBLIN, Ireland, Oct. 17, 2013 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets,...
Trinity Biotech plc to Announce Third Quarter Fiscal Year 2013 Financial Results
September 30, 2013 07:34 ET
|
Trinity Biotech plc
DUBLIN, Ireland, Sept. 30, 2013 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory...
Trinity Biotech Announces Quarter 2 Financial Results and Acquisition of Immco Diagnostics Inc.
July 30, 2013 09:38 ET
|
Trinity Biotech plc
DUBLIN, Ireland, July 30, 2013 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets,...
Trinity Biotech plc to Announce Second Quarter Fiscal Year 2013 Financial Results
July 23, 2013 10:29 ET
|
Trinity Biotech plc
DUBLIN, Ireland, July 23, 2013 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets,...
Trinity Biotech Announces Quarter 1 Results - EPS of 20 Cents, Premier Regulatory Approval in China and 33% Increase in Dividend to 20 Cents
April 25, 2013 08:34 ET
|
Trinity Biotech plc
DUBLIN, Ireland, April 25, 2013 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory...